MARKETING MEDICINES OTC LTDActive

Company number 08953814Private limited companyIncorporated 2014

Key figures

£180,650+35.3%
Net assets 2025/26
+40.4%
Average annual growth 2019/20–2025/26
050 k100 k150 k200 k2019/202020/212021/222022/232023/242024/252025/26

Like most small UK companies, MARKETING MEDICINES OTC LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k300 k2019/202020/212021/222022/232023/242024/252025/26
Filed accounts2019/20–2025/26
2021/222022/232023/242024/252025/26
Cash at bank and in hand74,917127,182117,681148,878211,853
Total assets100,816141,369135,575168,175211,853
Total liabilities35,50456,91139,74434,80531,347
Net assets / total equity65,81584,83696,083133,561180,650
Average number of employees22200

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: MARKETING MEDICINES OTC LTD

Company

MARKETING MEDICINES OTC LTD is a private limited company registered with Companies House under company number 08953814. It was incorporated on 24 Mar 2014. Its status is active. The registered office is in Tonbridge (TN11). Its nature of business (SIC 2007) is management consultancy activities other than financial management (70229).

Accounts

The latest accounts in the database are for 2025/26 (period ending 30 Sep 2026); the company files small company accounts (filleted). Net assets were £180,650, up 35.3% on the previous year. Cash at bank and in hand was £211,853. Total assets were £211,853 and total liabilities £31,347. The company had an average of 0 employees. Figures are available for 7 financial years (2019/20–2025/26).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Jan 2027. The next confirmation statement is due by 7 Apr 2027.